Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
LinkDoc Technology, founded in 2014 and headquartered in Beijing, China, is a data-driven, AI-enabled medical technology company operating in the healthcare and technology sectors. The company offers a range of services including big data processing, AI diagnosis and treatment, clinical trial matching, and digital therapeutics, all aimed at improving patient care and facilitating medical research.
Since its inception, LinkDoc Technology has successfully raised over $253 million through multiple funding rounds, with notable investors including Alibaba Health, China Investment Corporation, and Temasek. The company's last known valuation was $1 billion in 2018, demonstrating significant growth and investor interest in its innovative healthcare solutions.
As of now, there is no concrete information available regarding LinkDoc Technology's IPO prospects. The company has not made any official announcements about plans to go public. Without official statements or reliable reports, it would be premature to speculate on the likelihood or timing of a potential IPO.
Factors that could influence LinkDoc Technology's decision to pursue an IPO in the future may include market conditions in the healthcare technology sector, the company's financial performance, and its strategic growth plans. However, investors interested in LinkDoc Technology should keep in mind that any discussion about a potential IPO remains speculative until officially confirmed by the company or regulatory filings.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While LinkDoc Technology's IPO prospects remain uncertain, investors interested in the healthcare technology sector don't have to wait on the sidelines. At Linqto, we offer our members the opportunity to invest in promising private companies before they go public. Our platform provides access to a diverse range of pre-IPO investments, including potential leaders in the healthcare and technology sectors, with lower minimum investments than traditional private equity opportunities. This could allow you to potentially benefit from the growth of companies like LinkDoc Technology before they hit the public markets.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
